Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men

No abstract is available for this paper.

• Publication year

  2017

• Venue

  BJU International

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bju.13578PMID 27409523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Testosterone Treatment in Older Men.

  2018cited by this paper
• Testosterone and Sexual Function.

  2016cited by this paper
• The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review.

  2016cited by this paper
• Testosterone Therapy and Prostate Cancer.

  2016cited by this paper
• Low testosterone level is an independent risk factor for high‐grade prostate cancer detection at biopsy

  2016cited by this paper
• Testosterone therapy and prostate cancer

  2016cited by this paper
• THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.

  2016cited by this paper
• An update on the role of testosterone replacement therapy in the management of hypogonadism

  2016cited by this paper
• Effects of Testosterone Treatment in Older Men.

  2016cited by this paper
• PD09-06 PROSTATE CANCER IS LESS FREQUENT AND SEVERE IN HYPOGONADAL MEN TREATED ADEQUATELY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS COMPARED TO UNTREATED HYPOGONADAL CONTROLS

  2016cited by this paper
• Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies

  2015cited by this paper
• Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer.

  2015cited by this paper
• Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimen

  2015cited by this paper
• Prostate Cancer and Testosterone Replacement Therapy--What is the Risk?

  2015cited by this paper
• Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

  2015cited by this paper
• Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model

  2015cited by this paper
• Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men

  2015cited by this paper
• Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials

  2015cited by this paper
• Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.

  2015cited by this paper
• Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.

  2015cited by this paper
• Adverse effects of testosterone replacement therapy: an update on the evidence and controversy

  2014cited by this paper
• The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis

  2014cited by this paper
• Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study

  2014cited by this paper
• To Treat or Not to Treat with Testosterone Replacement Therapy: a Contemporary Review of Management of Late-Onset Hypogonadism and Critical Issues Related to Prostate Cancer

  2014cited by this paper
• Testosterone and weight loss: the evidence

  2014cited by this paper
• Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome

  2014cited by this paper
• Testosterone and Sexual Function

  2013cited by this paper
• Prostatic Diseases and Male Voiding Dysfunction Effects of 5-Year Treatment With Testosterone Undecanoate on Lower Urinary Tract Symptoms in Obese Men With Hypogonadism and Metabolic Syndrome

  2013cited by this paper
• IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

  2013cited by this paper
• 12-Month Observation of Testosterone Replacement Effectiveness in a General Population of Men

  2013cited by this paper
• Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men

  2013cited by this paper
• Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

  2012cited by this paper
• The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.

  2011cited by this paper
• Testosterone Concentrations in Diabetic and Nondiabetic Obese Men

  2010cited by this paper
• Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

  2010cited by this paper
• Identification of late-onset hypogonadism in middle-aged and elderly men.

  2010cited by this paper
• Registries for robust evidence.

  2009cited by this paper
• Prevalence of symptomatic androgen deficiency in men.

  2007cited by this paper
• Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.

  2007cited by this paper
• Prevalence of hypogonadism in males aged at least 45 years: the HIM study

  2006cited by this paper
• The influence of finasteride on the development of prostate cancer.

  2003cited by this paper
• Long‐term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 years

  1999cited by this paper

• Male hypogonadism and testosterone therapy: current clinical evidence and controversies

  2026cites this paper
• Late-onset hypogonadism: current methods of clinical diagnosis and treatment in Japan

  2025cites this paper
• Methods of correction of hypogonadism syndrome in men and long-term results of drug treatment

  2025cites this paper
• Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

  2025cites this paper
• Testosterone Replacement Therapy in Hypogonadal Men with a Prostate Cancer Diagnosis: A British Society for Sexual Medicine Consensus Statement

  2025cites this paper
• European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie's Disease.

  2025cites this paper
• Prostate Risk and Monitoring During Testosterone Replacement Therapy.

  2024cites this paper
• Testosterone and resistance training improved physical performance and reduced fatigue in frail older men: 1 year follow-up of a randomized clinical trial

  2024cites this paper
• Beneficial effects of exercise, testosterone, vitamin D, calcium and protein in older men—A randomized clinical trial

  2024cites this paper
• Que faire en cas d’hypogonadisme chez un patient qui a été pris en charge pour un cancer de la prostate localisé ?

  2024cites this paper
• The impact of testosterone in men's health.

  2023cites this paper
• Male hypogonadism - summary according to EAU guidelines

  2023cites this paper
• Long-Term Outcomes of Testosterone Treatment in Men: A T4DM Post-Randomisation Observational Follow-Up Study.

  2023cites this paper
• Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis

  2023cites this paper
• Evolution of the views on the role of testosterone in prostate cancer. Literature review

  2023cites this paper
• The Illusory Case for Treatment of an Invented Disease

  2022cites this paper
• Testosterone Therapy in Men on Active Surveillance

  2022cites this paper
• The effect of different administrations of testosterone therapy on adverse prostate events: A Bayesian network meta-analysis

  2022cites this paper
• Clinical significance of prostate volume and testosterone reduction on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy

  2022cites this paper
• Testosterone therapy and cancer risks among men in the SEER-Medicare linked database

  2022cites this paper
• Andrology centres accredited by the European Academy of Andrology

  2022cites this paper
• Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review

  2022cites this paper
• Hypogonadism and urologic surgeries: a narrative review

  2022influential citation
• Androgens, aging, and prostate health

  2022cites this paper
• Ageing male (part 2): Management of functional hypogonadism in older men, a patient-centric holistic approach.

  2022cites this paper
• Testosterone Treatment and the Risk of Prostate Adverse Events.

  2022cites this paper
• Das Altern des Mannes

  2022cites this paper
• Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.

  2021cites this paper
• Bipolar Androgen Therapy in the management of prostate cancer

  2021cites this paper
• Testosterone serum levels in elderly fall-prone men do not correlate with age or performance in the 30 seconds chair stand test

  2021cites this paper
• The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy.

  2021cites this paper
• Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms

  2021cites this paper
• Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative Review

  2021cites this paper
• The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis

  2020cites this paper
• Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians

  2020cites this paper
• Testosterone Therapy: What We Have Learned From Trials.

  2020cites this paper
• Iatrogénie médicamenteuse et troubles de la prostate

  2020cites this paper
• Histopathologic Changes in a Hypogonadal Male on Exogenous Testosterone Diagnosed With Prostatic Adenocarcinoma: A Case Report

  2020cites this paper
• Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer.

  2020cites this paper
• Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system

  2020cites this paper
• Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects

  2020cites this paper
• Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men

  2020cites this paper
• Aging and the Male Reproductive System.

  2019cites this paper
• The Testosterone Effect on Metabolic and Urologic Outcomes in Patients with Nonfunctioning Pituitary Macroadenomas and Hypogonadotropic Hypogonadism

  2019cites this paper
• Hypogonadism and Testosterone Therapy in Elderly Men

  2019cites this paper
• Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database

  2019cites this paper
• Testosterone Management in Aging Males: Surveying Clinical Practices of Urologists and Endocrinologists in Israel

  2019cites this paper
• Testosterone and Benign Prostatic Hyperplasia.

  2019cites this paper
• Safety of testosterone therapy in men with prostate cancer

  2019influential citation
• Percepção de homens sobre a influência da alimentação no câncer de próstata

  2019cites this paper
• Glycosylation products in prostate diseases.

  2019cites this paper
• Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men with Late-Onset Hypogonadism.

  2019cites this paper
• Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency

  2019cites this paper
• DER HYPOGONADALE DIABETIKER : EINE INTERDISZIPLINÄRE BETRACHTUNG

  2019cites this paper
• Klinefelter syndrome: more than hypogonadism.

  2018cites this paper
• Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

  2018cites this paper
• Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review

  2018cites this paper
• Klinefelter syndrome: From pediatrics to geriatrics

  2018cites this paper
• Does testosterone replacement therapy relieve lower urinary tract symptoms in men with hypogonadism?

  2018cites this paper
• Central Hypogonadism in the Male: Physiopathology, Diagnosis and Treatment

  2018cites this paper
• Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro‐oncologists' opinions and practice

  2018cites this paper
• Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms

  2018cites this paper
• Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome

  2018cites this paper
• The Role of Testosterone Therapy in the Setting of Prostate Cancer

  2018cites this paper
• Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.

  2018cites this paper
• Daily subcutaneous testosterone for management of testosterone deficiency.

  2018cites this paper
• Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone

  2018cites this paper
• Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer

  2018cites this paper
• Hypothalamic-Pituitary Diseases

  2018cites this paper
• Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).

  2017cites this paper
• Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.

  2017cites this paper
• Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis

  2017influential citation
• Testosteronsubstitution — wann und wie?

  2017cites this paper
• Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer

  2017cites this paper
• Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male.

  2017cites this paper
• Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes.

  2017cites this paper
• Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States.

  2017cites this paper
• Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members.

  2017cites this paper
• Quality of Life and Sexual Function Benefits Effects of Long-Term Testosterone Treatment: Longitudinal Results from the Registry of Hypogonadism (RHYME)

  2017cites this paper
• Testosteronsubstitution – wann und wie?

  2017cites this paper
• A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer

  2017cites this paper
• Effect of testosterone therapy combined with a very low caloric diet in obese men: a randomised controlled trial

  2017cites this paper
• Mythology and reality should never be confused (but often are)

  2017cites this paper
• Androgens: Pharmacological Use and Abuse

  2016cites this paper
• Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?

  2016influential citation